Davis, Elena Goetz
Keller, Jennifer
Hallmayer, Joachim
Pankow, Heather Ryan
Murphy, Greer M. Jr.
Gotlib, Ian H.
Schatzberg, Alan F.
Article History
Received: 30 August 2017
Accepted: 13 September 2017
First Online: 10 January 2018
Competing interests
: Dr. Schatzberg has been a consultant for Alkermes, Clintara, Forum (EnVivo), Lundbeck/Takeda, McKinsey, Myriad Genetics, Maurex, Neuronetics, and Sunovion; and has equity in Amestix, Delpor, Gilead, Incyte, Merck, Neurocrine, Seattle Genetics, Titan, Xhale, and Corcept Therapeutics, Inc., where he is also the co-founder. He has received grant support from Janssen and is a named inventor on pharmacogenetic and antiglucocorticoid use patents on prediction of antidepressant response. Dr. Greer Murphy has been a consultant for Brain Resource, Ltd. The remaining authors declare that they have no competing financial interests.